An echo also at that time showed AS with thickening of the aortic valve leaflets, peak aortic gradient of 52, mean of 35 and a valve area 1.0 cm squared, trace MR and trace TR.
Zocor 20 mg q.d.
Aldactazide 50 mg q.d.
HOSPITAL COURSE:   Following cardiac catheterization, the patient was discharged home and scheduled for aortic valve replacement and coronary artery bypass grafting times one as a postoperative admit.
On [**2175-2-9**], the patient was admitted to the Operating Room at which time he underwent AVR coronary artery bypass graft times one, please see the OR report for full details.
In summary, the patient had a coronary artery bypass graft times one with a saphenous vein graft to OM1 and aortic valve replacement with a #21 mm [**Last Name (un) 3843**]-[**Doctor Last Name **] bovine pericardial valve.
He tolerated the operation well and was transferred from the Operating Room to the Cardiothoracic Intensive Care Unit.
His anesthesia was reversed and his sedation discontinued.
A second attempt at awakening the patient was met again with extreme agitation and the patient, again required resedation.
The following morning, the patient's sedation was discontinued and he was successfully weaned from the ventilator and extubated.
Aspirin 325 q.d.
Metoprolol 50 b.i.d.
Lasix 40 b.i.d.
Simvastatin 20 q.d.
Potassium Chloride 20 milliequivalents b.i.d.
Percocet 5/325 one to two tablets q. four hours p.r.n.
Ibuprofen 400 mg q. six hours p.r.n.
Aortic stenosis status post aortic valve replacement with a #21 [**Last Name (un) 3843**]-[**Doctor Last Name **] bovine pericardial valve.
Coronary artery disease status post coronary artery bypass grafting times one with saphenous vein graft to OM1.
